COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,886 Articles (22,568 medRxiv, 8,318 bioRxiv)

Most recent first Previous |  Page 844: Articles 8431-8440  | Next

Bebtelovimab, alone or together with bamlanivimab and etesevimab, as a broadly neutralizing monoclonal antibody treatment for mild to moderate, ambulatory COVID-19
Dougan, M., Azizad, M., Chen, P., Feldman, B., Frieman, M., Igbinadolor, A., Kumar, P. N., Morris, J., Potts, J., Baracco, L., Macpherson, L., Kallewaard, N., Patel, D., Hufford, M. M., Wietecha, L., Chigutsa, E., Demmon, S. L., Jones, B. E., Nirula, A., Skovronsky, D., Williams, M., Gottlieb, R. L.
10.1101/2022.03.10.22272100 — Posted: 2022-03-12
Possible Role of P-selectin Adhesion in Long-COVID: A Comparative Analysis of a Long-COVID Case Versus an Asymptomatic Post-COVID Case
Tarasev, M., Gao, X., Mota, S., Ferranti, M., Zaidi, A. U., Hannan, B., Hines, P.
10.1101/2022.03.09.22271297 — Posted: 2022-03-12
SARS-CoV-2 seroconversion in response to infection and vaccination: A time series local study in Brazil
Huergo, L., Paula, N. M., Goncalves, A. C. A., Kluge, C. H. S., Martins, P. H. S. A., Camargo, H. S. C., Santana, T. P., Farias, L. R. P., Lima, E. S., Aldrighi, J. D., Jacotenski, G. T., Vargas, L. R., Costa, G., Weissheimer, K. V., Nazario, M. G., Teixeira, K. N., Conzentino, M. d. S.
10.1101/2022.03.10.22271805 — Posted: 2022-03-12
Current epidemiological situation of COVID-19 in the Republic of Belarus: characteristics of the epidemic process, sanitary and anti-epidemic measures
Dashkevich, A. M., Kolomiets, N. D., Vysotskaya, V. S., Hlinskaya, I. N., Skuranovich, A. L., Tarasenka, A. A., Karaban, I. A., Gasich, E. L.
10.1101/2022.03.10.22271815 — Posted: 2022-03-12
Seroneutralization of Omicron BA.1 and BA.2 in patients receiving anti-SARS-CoV-2 monoclonal antibodies.
Bruel, T., Hadjadj, J., Maes, P., Planas, D., Seve, A., Staropoli, I., Guivel-Benhassine, F., Porrot, F., Bolland, W.-H., Nguyen, Y., Casadevall, M., Charre, C., Pere, H., Veyer, D., Prot, M., Baidaliuk, A., Cuypers, L., Planchais, C., Mouquet, H., Baele, G., Mouthon, L., Hocqueloux, L., Simon-Loriere, E., Andre, E., Terrier, B., Prazuck, T., Schwartz, O.
10.1101/2022.03.09.22272066 — Posted: 2022-03-12
Blood group O and post-COVID-19 syndrome
Diaz-Salazar, S., Navas, R., Sainz-Maza, L., Fierro, P., Maamar, M., Artime, A., Basterrechea, H., Petitta, B., Lamadrid, C., Pedraja, L., Gandara-Samperio, C., Pini, S., Olmos, J. M., Ramos-Barron, C., Pariente, E., Hernandez, J. L.
10.1101/2022.03.10.22272197 — Posted: 2022-03-12
Evidence for SARS-CoV-2 Delta and Omicron co-infections and recombination
Bolze, A., White, S., Basler, T., Dei Rossi, A., Roychoudhury, P., Greninger, A. L., Hayashibara, K., Wyman, D., Kil, E., Dai, H., Cassens, T., Tsan, K., Nguyen, J., Ramirez, J., Carter, S., Cirulli, E. T., Schiabor Barrett, K., Belda-Ferre, P., Washington, N. L., Jacobs, S., Sandoval, E., Becker, D., Lu, J. T., Isaksson, M., Lee, W., Luo, S.
10.1101/2022.03.09.22272113 — Posted: 2022-03-12
Prevention of SARS-CoV-2 airborne transmission in a workplace based on CO2 sensor network
Yokogawa, S., Ishigaki, Y., Kitamura, H., Saito, A., Kawauchi, Y.
10.1101/2022.03.04.22271934 — Posted: 2022-03-12
Different Covid-19 Outcomes Among Systemic Rheumatic Diseases: A Nation-wide Cohort Study
Bournia, V.-K., Fragoulis, G., Mitrou, P., Mathioudakis, K., Tsolakidis, A., Konstantonis, G., Tseti, I., Vourli, G., Tektonidou, M. G., Paraskevis, D., Sfikakis, P. P.
10.1101/2022.03.11.22271887 — Posted: 2022-03-12
Pharmacokinetics of favipiravir in adults with mild COVID-19 in Thailand
Manosuthi, W., Prasanchaimontri, I.-o., Niyomnaitham, S., Sirijatuphat, R., Charoenpong, L., Copeland, K., Cressey, T. R., Mokmued, P., Chokephaibulkit, K.
10.1101/2022.03.09.22271220 — Posted: 2022-03-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).